European Union -
English -
EMA (European Medicines Agency)
nucala
glaxosmithkline trading services - mepolizumab - asthma - drugs for obstructive airway diseases, - severe eosinophilic asthmanucala is indicated as an add-on treatment for severe refractory eosinophilic asthma in adults, adolescents and children aged 6 years and older .chronic rhinosinusitis with nasal polyps (crswnp)nucala is indicated as an add-on therapy with intranasal corticosteroids for the treatment of adult patients with severe crswnp for whom therapy with systemic corticosteroids and/or surgery do not provide adequate control.eosinophilic granulomatosis with polyangiitis (egpa)nucala is indicated as an add-on treatment for patients aged 6 years and older with relapsing-remitting or refractory eosinophilic granulomatosis with polyangiitis (egpa).hypereosinophilic syndrome (hes)nucala is indicated as an add-on treatment for adult patients with inadequately controlled hypereosinophilic syndrome without an identifiable non-haematologic secondary cause.
United Kingdom -
English -
MHRA (Medicines & Healthcare Products Regulatory Agency)
nucala 100mg powder for solution for injection vials
glaxosmithkline uk ltd - mepolizumab - powder for solution for injection - 100mg
Singapore -
English -
HSA (Health Sciences Authority)
nucala powder for solution for injection 100mg
glaxosmithkline pte ltd - mepolizumab - injection, powder, lyophilized, for solution - mepolizumab 100mg/vial
Singapore -
English -
HSA (Health Sciences Authority)
nucala solution for injection in pre-filled pen 100mgml
glaxosmithkline pte ltd - mepolizumab - injection, solution - mepolizumab 100mg/ml
Singapore -
English -
HSA (Health Sciences Authority)
nucala solution for injection in pre-filled syringe 100mgml
glaxosmithkline pte ltd - mepolizumab - injection, solution - mepolizumab 100mg/ml
Singapore -
English -
HSA (Health Sciences Authority)
nucala solution for injection in pre-filled syringe 40mg0.4ml
glaxosmithkline pte ltd - mepolizumab - injection, solution - mepolizumab 40mg/0.4ml
Canada -
English -
Health Canada
nucala powder for solution
glaxosmithkline inc - mepolizumab - powder for solution - 100mg - mepolizumab 100mg - immunosuppressive agents
Canada -
English -
Health Canada
nucala solution
glaxosmithkline inc - mepolizumab - solution - 100mg - mepolizumab 100mg - immunosuppressive agents
Canada -
English -
Health Canada
nucala solution
glaxosmithkline inc - mepolizumab - solution - 100mg - mepolizumab 100mg - immunosuppressive agents
Saudi Arabia -
English -
SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء
nucala solution for injection
glaxo saudi arabia ltd, saudi arabia - mepolizumab - solution for injection - 100 mg/ml